|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 January 2002, Vol. 99, No. 2, pp. 555-560
IMMUNOBIOLOGY
CD4+CD25+ T-cell development is regulated
by at least 2 distinct mechanisms
Akira Suto,
Hiroshi Nakajima,
Kei Ikeda,
Shuichi Kubo,
Toshinori Nakayama,
Masaru Taniguchi,
Yasushi Saito, and
Itsuo Iwamoto
From the Department of Internal Medicine II, the Core
Research for Evolutional Science and Technology Project, and the
Department of Molecular Immunology, Graduate School of Medicine, Chiba
University, Japan; and the Department of Immunology, Tokyo Metropolitan
Institute of Medical Science, Tokyo Metropolitan Organization for
Medical Research, Japan.
 |
Abstract |
It has recently been shown that
CD4+CD25+ T cells are immunoregulatory T cells
that prevent CD4+ T-cell-mediated organ-specific
autoimmune diseases. In this study, the regulatory mechanism of
CD4+CD25+ T-cell development were investigated
using T-cell receptor (TCR) transgenic mice. It was found that
CD4+CD25+ T cells preferentially expressed the
endogenous TCR chain in DO10+ TCR transgenic mice
compared with CD4+CD25 T cells. Moreover, it
was found that CD4+CD25+ thymocytes were
severely decreased in DO10+ TCR- / mice
in positively selecting and negatively selecting backgrounds, whereas
CD4+CD25 thymocytes efficiently developed by
transgenic TCR in DO10+ TCR- / mice in
positively selecting backgrounds, indicating that the appropriate
affinity of TCR to major histocompatibility complex (MHC) for the
development of CD4+CD25+ thymocytes is
different from that of CD4+CD25 thymocytes
and that a certain TCR-MHC affinity is required for the development of
CD4+CD25+ thymocytes. Finally, it was found
that, in contrast to thymus, CD4+CD25+ T cells
were readily detected in spleen of DO10+
TCR- / mice in positively selecting backgrounds and
that splenic CD4+CD25+ T cells, but not
CD4+CD25+ thymocytes, were significantly
decreased in B-cell-deficient mice, suggesting that B cells may
control the peripheral pool of CD4+CD25+ T
cells. Together, these results indicate that the development of
CD4+CD25+ T cells in thymus and the homeostasis
of CD4+CD25+ T cells in periphery are regulated
by distinct mechanisms.
(Blood. 2002;99:555-560)
© 2002 by The American Society of Hematology.
 |
Introduction |
Immunologic tolerance is a feature of the immune
system essential for discrimination between self and nonself. Recent
data suggest that in addition to clonal deletion and anergy, regulatory T cells play a significant role in the generation and maintenance of
tolerance.1-4 The term regulatory T cells is used for a
variety of immunoregulatory cells that can be subdivided into a number of subsets based on expression of cell surface proteins and pattern of
cytokine production.1-4 Because these subsets of
regulatory T cells have been characterized in experimental models using
different assays, the interrelationship between the subsets is
difficult to understand.1-4
One of the best-characterized subsets of CD4+ regulatory T
cells is defined by its constitutive expression of interleukin-2 receptor (IL-2R)- chain (CD25) (CD4+CD25+ T
cells).3,4 CD4+CD25+ T cells
constitute approximately 10% of peripheral CD4+ T cells in
nonimmunized naive mice and exhibit a broad spectrum of
autoimmunity-preventive activity.5-8
CD4+CD25+ T cells are naturally anergic and, on
T-cell receptor (TCR)-mediated activation, potently suppress the
proliferation of CD4+CD25 T cells by an
antigen-nonspecific mechanism.9-11 Molecular mechanisms by
which CD4+CD25+ T cells mediate suppression are
unclear but seem to be independent of cytokine
production9,10 and dependent on cell
contact9,10 and to require constitutive expression of
CTLA-4.12,13
CD4+CD25+ T cells can be subdivided by the
expression pattern of CD45RBhigh or CD45RBlow,
CD38+ or CD38 , CD69+ or
CD69 , or CD62Lhigh or
CD62Llow.5,9,11,14 Although these findings
suggest that CD4+CD25+ T cells might be
heterogeneous and composed of a mixture of regulatory T cells and
activated conventional T cells, it has recently been shown that the
anergic and suppressive properties of CD4+CD25+
T cells cannot be subdivided to a smaller subpopulation defined by the
expression levels of CD45RB, CD62L, CD38, or CD69.11,14 Therefore, CD4+CD25+ T cells may represent a
relatively homogeneous population of regulatory T cells.
Precise signals that promote the development of
CD4+CD25+ T cells remain elusive, but
considerable evidence suggests that costimulatory molecules and
cytokines play important roles. It has been shown that
CD4+CD25+ T cell levels are severely decreased
in mice lacking CD288 or CD40L,15 indicating
that signaling by CD28 and by CD40L regulates the number of
CD4+CD25+ T cells in periphery. In addition,
CD4+CD25+ T-cell levels are decreased in mice
lacking IL-216 or IL-2R component,17
indicating that IL-2 signaling also regulates the number of
CD4+CD25+ T cells.
The CD25+ population constitutes approximately 5% of
CD4+CD8 CD3high mature thymocytes
in normal mice (CD4+CD25+ thymocytes), and the
CD4+CD25+ thymocytes exhibit a similar
functional property to that found in peripheral
CD4+CD25+ T cells.18 Moreover,
thymectomy on day 3 of life decreases the number of
CD4+CD25+ T cells from the peripheral lymphoid
organ.6 Furthermore, CD4+CD25+ T
cells cannot be produced by in vitro culture of
CD4+CD25 T cells.7,9,14 Taken
together, these findings suggest that CD4+CD25+
T cells arise in the thymus and migrate to the periphery.
Recently, Itoh et al18 have shown that
CD4+CD25+ T cells can develop in TCR transgenic
mice of wild-type background but not of RAG-2-deficient background.
Thus, it is possible that B cells,  T cells, or natural killer
(NK) T cells, all of which are absent in TCR transgenic
RAG-2-deficient mice but are present in TCR transgenic mice, are
required for the development of CD4+CD25+ T
cells. It is also possible that the expression of endogenous TCR and
the subsequent interaction with self-major histocompatibility complex
(MHC) at a certain affinity is required for the development of these
cells. However, a great deal of uncertainty remains about differentiation factors and antigen specificity of
CD4+CD25+ T cells.
In the current study, to determine whether positive or negative
selection in thymus regulates the development of
CD4+CD25+ T cells, we investigated
CD4+CD25+ T-cell development in mice expressing
TCR transgene in positively selecting and negatively selecting MHC
backgrounds. We also investigated the requirement of B cells and NK T
cells for the development of CD4+CD25+ T cells.
Our results indicate that the size of the
CD4+CD25+ T-cell pool in periphery is regulated
at least 2 distinct levels. First, in the thymus, where
CD4+CD25+ T cells are produced, a certain range
of TCR-MHC affinity is required for their development. In addition, B
cells, but not NK T cells, regulate the expansion and/or survival of
CD4+CD25+ T cells in periphery.
 |
Materials and methods |
Mice
BALB/c and C57BL/6 mice were purchased from Japan SLC (Shizuoka,
Japan). Immunoglobulin µ-chain-deficient mice19 and NK T-cell-deficient mice20 of C57BL/6 background were
previously described. Ovalbumin-specific DO11.10 (DO10+)
TCR transgenic mice21 were backcrossed to BALB/c mice for more than 10 generations. BALB/c RAG-2 /
mice22 were a kind gift from Dr T. Saito (Chiba
University). TCR- / mice23
(H-2b/b) were crossed with DO10+ mice
(H-2d/d), and then offspring DO10+
TCR- +/ H-2d/b mice were crossed with
TCR- +/ H-2d/b mice to develop
DO10+ TCR- / mice in H-2d/d,
H-2d/b, or H-2b/b background. Expressions of
DO10+ transgene and H-2 haplotypes were determined by
fluorescence-activated cell sorter analysis (FACS), as described below.
The genotype of TCR- allele was determined by polymerase chain
reaction using the following primer pairs: to detect TCR- wild-type
allele, 5'-aagatcctcggtctcaggacagc-3' and
5'-ggtaggtggcgttggtctctttg-3'; to detect TCR- mutant allele,
5'-attcgcagcgcatcgccttctatcg-3' and 5'-ggtaggtggcgttggtctctttg-3'.
Homozygosity for the TCR- mutant allele was confirmed, using FACS,
by the absence of T cells that express endogenous TCR V- 2. Mice were
housed in micro-isolator cages under pathogen-free conditions; 8- to
10-week-old mice were used in all experiments.
Flow cytometric analysis
Cells from thymus and spleen were stained and analyzed on a
FACScalibur (Becton Dickinson, San Jose, CA) using CELLQuest software. For direct staining, the following conjugated antibodies were purchased
from PharMingen (San Diego, CA): anti-CD3 fluorescein isothiocyanate
(FITC) (145-2C11), anti-CD4 FITC, phycoerythrin (PE), PerCP,
allophycocyanin (APC) (H129.19), anti-B220 FITC (RA3-6B2), anti-CD8 FITC, APC (53.6.7), anti-CD25 PE (PC61), anti-CD25 FITC (7D4),
anti-CD45RB FITC (16A), anti-NK-1.1 PE (PK136), anti-TCR V- 2 FITC
(B20.1), anti-TCR V- 11 FITC (RR8-1), anti-TCR V 8 FITC (F23.1),
anti-H-2Kb PE (AF6-88.5), anti-H-2Kd FITC
(SF1-1.1), anti-I-Ab PE (AF6-120.1), and
anti-I-Ad FITC (AMS-32.1). KJ1-26 monoclonal antibody,
anti-idiotype for DO10 TCR,24 was purified from
supernatants of hybridoma cells using protein G columns (Pharmacia,
Uppsala, Sweden) and conjugated to FITC or biotin. Before staining, Fc
receptors were blocked with anti-CD16/32 antibody (2.4G2; PharMingen).
Annexin V staining
After cells were stained with anti-CD4 APC and anti-CD25 PE and
washed twice with phosphate-buffered saline-1% bovine serum albumin,
cells were stained with annexin V-FITC (R&D Systems, Minneapolis, MN)
according to the manufacturer's instructions. Cells were then
analyzed on a FACScalibur.
Data analysis
Data are summarized as mean ± SD. Statistical analysis of
the results was performed by the unpaired t test.
P < .05 was considered significant.
 |
Results |
CD4+CD25+ T cells preferentially express
the second TCR- chain in TCR transgenic mice
It is well established that allelic exclusion of the TCR- chain
is almost perfect, whereas that of the TCR- chain is
incomplete.25 Thus, a considerable fraction of T cells
express 2 different TCR- pairs.26 Because it has
been shown that CD4+CD25+ T cells can develop
in TCR transgenic mice of wild-type background but not of
RAG-2-deficient background,18 it is possible that CD4+CD25+ T cells preferentially express the
endogenous TCR- chain and that signaling through the endogenous
TCR- chain coupled with the transgenic TCR- chain is involved in
the development of CD4+CD25+ T cells in TCR
transgenic mice. To examine this possibility, we first investigated the
frequency of CD4+ T cells that express both transgenic TCR
(recognized by anti-idiotypic monoclonal antibody, KJ1-26) and one of
the endogenous TCR V- chains, V- 2, in the CD25+ or
CD25 population in ovalbumin-specific TCR transgenic
(DO10+) mice. As shown in Figure
1A, splenic CD4+ T cells that
express transgenic TCR and TCR V- 2 chain were found at a higher
frequency in CD4+CD25+ T cells than in
CD4+CD25 T cells
(CD4+CD25+ T cells 12.0% ± 1.6% versus
CD4+CD25 T cells 2.5% ± 1.0%, mean ± SD; n = 5; P < .001). Moreover, CD4+ T
cells that express both transgenic TCR and TCR V- 11 were also found
at a higher frequency in CD4+CD25+ T cells
(data not shown). These results suggest that
CD4+CD25+ T cells preferentially express the
second TCR- chain in DO10+ mice. For controls, we
performed the same analysis for splenocytes in DO10+
RAG-2-deficient mice. We found that, consistent with the previous report by Itoh et al,18 CD4+CD25+
T cells were almost absent in these mice (Figure 1B) and that no
CD4+CD25 T cell expressed TCR V- 2 (Figure
1B) or TCR V- 11 (data not shown) in these mice.

View larger version (32K):
[in this window]
[in a new window]
| Figure 1.
CD4+CD25+ T cells preferentially
express the second TCR chain in DO10+ TCR transgenic
mice.
Single-cell suspension of splenocytes from DO10+ mice (A)
and DO10+ RAG-2 / mice (B) were stained with
anti-TCR V 2 FITC, anti-CD25 PE, anti-CD4 PerCP, and KJ1-26 biotin.
After biotinylated antibody was visualized with streptavidin APC, cells
were analyzed on FACScalibur. Shown are representative FACS profiles of
CD4 versus CD25 of CD4+ splenocytes (upper panels) and
KJ1-26 versus V 2 (lower panels) on either
CD4+CD25+ T cells or
CD4+CD25 T cells from 5 mice in each
group.
|
|
Dual TCR- expression is not essential for the development of
CD4+CD25+ T cells
CD4+CD25+ T cells preferentially expressed
dual TCR- chains in DO10+ mice (Figure 1A). To determine
whether dual TCR- expression is required for the development of
CD4+CD25+ T cells, we investigated the
development of CD4+CD25+ T cells in TCR-
heterozygous mice, in which only one allele of TCR- was available
for the expression. As shown in Figure 2,
the number of CD4+CD25+ T cells in thymus and
in spleen was normal in TCR- heterozygous mice, suggesting that
though CD4+CD25+ T cells preferentially
expressed the second TCR- chain in TCR transgenic mice, dual TCR-
expression was not essential for the development of
CD4+CD25+ T cells.

View larger version (36K):
[in this window]
[in a new window]
| Figure 2.
Dual TCR expression is not essential for the
development of CD4+CD25+ T cells.
(A) Thymocytes from TCR +/ mice and
TCR +/+ mice were stained with anti-CD3 FITC, anti-CD25
PE, anti-CD8 APC, and anti-CD4 PerCP. Shown are representative FACS
profiles of CD4 versus CD25 on a CD4+
CD8 CD3high population. FACS profile of CD4
versus CD8 and cell number of thymocytes was indistinguishable between
TCR +/ mice and TCR +/+ mice (data not
shown). (B) Splenocytes from TCR +/ mice and
TCR +/+ mice were stained with anti-CD25 PE and anti-CD4
FITC. Shown are representative FACS profiles of CD4 versus CD25 on the
CD4+ population from 5 mice in each group.
|
|
CD4+CD25+ thymocytes are severely decreased
in DO10+ TCR- / mice in positively
selecting and negatively selecting backgrounds
Because CD4+CD25+ T cells are absent in
DO10+ RAG-2 / mice (Figure 1B) and because
CD4+CD25+ T cells preferentially express the
second TCR- chain in DO10+ mice (Figure 1A), the
expression of endogenous TCR- chain and subsequent interaction with
self-MHC at an appropriate affinity may be required for the development
of CD4+CD25+ T cells. To test this possibility,
we investigated the development of CD4+CD25+ T
cells in DO10+ TCR- -deficient (TCR- /
) mice (Figure 3). Indeed, the frequency
of the CD25+ population in
CD4+CD8 mature thymocytes was severely
decreased in DO10+ TCR- / mice with
positively selecting H-2d background compared with that in
DO10+ TCR- +/+ mice (Figure 3B). In contrast,
no significant difference was observed in the number of conventional
CD4+CD25 mature thymocytes between
DO10+ TCR- / mice and
DO10+ TCR- +/+ mice (Figure 3B).
These results indicate that expression of the endogenous TCR- chain
is required for the development of CD4+CD25+ T
cells in DO10+ mice. In addition, they indicate that the
appropriate affinity of TCR to self-MHC for the development of
CD4+CD25+ thymocytes is different from that of
CD4+CD25 thymocytes and that the interaction
of TCR with self-MHC at a certain affinity is essential for the
development of CD4+CD25+ thymocytes.

View larger version (55K):
[in this window]
[in a new window]
| Figure 3.
CD4+CD25+ thymocytes are
severely decreased in DO10+
TCR / mice in positively selecting and
negatively selecting backgrounds.
(A, B) Thymocytes from DO10+ mice
(H-2d/d), DO10+ TCR / mice
(H-2d/d), and DO10+ TCR /
mice (H-2b/b) were stained with KJ1-26 FITC, anti-CD25 PE,
anti-CD8 APC, and anti-CD4 PerCP. Shown are representative FACS
profiles of CD4 versus CD8 on total thymocytes (A) and CD4 versus CD25
on CD4+ CD8 KJ1-26high thymocytes
(B) from 5 mice in each group. The numbers of thymocytes are as
follows: DO10+ TCR +/+
H-2d/d mice (10.8 ± 2.6 × 107),
DO10+ TCR / H-2d/d mice
(13.2 ± 3.0 × 107), and DO10+
TCR / H-2b/b mice
(0.6 ± 0.2 × 107) (n = 5 mice each;
P < .01). (C) Splenocytes from DO10+
H-2d/d mice, DO10+ TCR /
H-2d/d mice, and DO10+ TCR /
H-2b/b mice were stained with anti-CD25 PE and anti-CD4
FITC. Shown are representative FACS profiles of CD4 versus CD25 on
splenocytes from 5 mice in each group.
|
|
We next analyzed CD4+CD25+ T-cell development
by transgenic TCR in DO10+ mice in a negatively selecting
H-2b background.27,28 For this purpose, we
investigated DO10+ TCR- / mice to exclude
the effect of endogenous TCR- expression. Interestingly, the number
of total thymocytes in DO10+ TCR- / mice
was severely decreased in H-2b background
(DO10+ TCR- / H-2b mice
compared with DO10+ TCR- /
H-2d mice; 0.6 ± 0.2 × 107 versus
13.2 ± 3.0 × 107; n = 5 each;
P < .001). Most thymocytes were within the
CD4 CD8 stage (Figure 3A); consequently, the
number of CD4+CD8 thymocytes was severely
decreased in these mice. When gated on the
CD4+CD8 thymocytes that could escape from
negative selection in DO10+ TCR- / mice
in H-2b background, the frequency of the CD25+
population was still severely decreased (Figure 3B). These results suggest that CD4+CD25+ T cells could not
develop when the affinity between TCR and MHC was so high.
Interestingly, though the number of CD4+CD25+
thymocytes was severely decreased in DO10+
TCR- / mice, CD4+CD25+ T
cells were readily observed in the spleens of DO10+
TCR- / mice in H-2d background (Figure
3C). The population of CD4+CD25+ T cells was
also approximately 2-fold in the spleens of DO10+
TCR- +/+ mice compared with that of
CD4+CD25+ thymocytes (Figure 3B-C). Most
splenic CD4+CD25+ T cells in DO10+
TCR- / mice and DO10+
TCR- +/+ mice were of the CD45RBlow
CD69 phenotype, similar to that in wild-type mice (data
not shown). These results suggest that there existed some homeostatic
machinery that regulated the size of the
CD4+CD25+ T-cell pool in periphery.
B cells but not natural killer T cells regulate the peripheral
pool of CD4+CD25+ T cells
CD4+CD25+ T cells exist in the spleens of
DO10+ TCR- / H-2d mice
(Figure 3C) but not in spleens of DO10+
RAG-2 / mice (Figure 1B). Thus, it is possible that a
certain population of cells absent in RAG-2-deficient mice regulates
the size of the CD4+CD25+ T-cell pool in
periphery. The possibility that B cells might affect
CD4+CD25+ T-cell development was examined by
flow cytometric analyses of CD4+CD25+ T cells
in µ-chain-deficient mice, which lack mature B cells.19 Interestingly, a profound decrease of splenic
CD4+CD25+ T cells was observed in
µ-chain-deficient mice (Figure 4A).
Less than 7% of CD4+ T cells in µ-chain-deficient mice
expressed CD25 compared with 13% in wild-type mice (n = 5 each)
(Figure 4A). Because the absolute number of splenic T cells was
decreased in µ-chain-deficient mice, the number of splenic
CD4+CD25+ T cells was significantly decreased
in µ-chain-deficient mice (approximately 20% of wild-type levels;
P < .001; Figure 4B). Interestingly, in contrast to
splenic CD4+CD25+ T cells, the number of
CD25+ population in CD4+ CD8
mature thymocytes was normal in µ-chain-deficient mice (Figure 5). Taken together, these results
indicate that though the development of
CD4+CD25+ T cells in thymus does not require
help from B cells, the size of CD4+CD25+ T-cell
pool in periphery is regulated by B cells. In contrast, the number of
splenic CD4+CD25+ T cells (Figure 4) and
CD4+CD25+ thymocytes (Figure 5) was normal in
NK T cell-deficient mice, indicating that NK T cells are not essential
for the development of CD4+CD25+ T
cells.

View larger version (30K):
[in this window]
[in a new window]
| Figure 4.
Splenic CD4+CD25+ T cells are
decreased in µ-chain-deficient mice but not in NK T-cell-deficient
mice.
Splenocytes from µ-chain-deficient mice, NK T-cell-deficient mice,
and wild-type (WT) mice were stained with anti-CD25 PE and anti-CD4
FITC. Shown are representative FACS profiles of CD4 versus CD25 on the
CD4+ population (A) and the absolute number of
CD4+CD25+ T cells in spleen (B) from 4 to 5 mice in each group. *Significantly different from the mean value of
wild-type mice; *P < .001.
|
|

View larger version (20K):
[in this window]
[in a new window]
| Figure 5.
CD4+CD25+ thymocytes can develop
normally in µ-chain-deficient mice and NK T-cell-deficient mice.
Thymocytes from µ-chain-deficient mice, NK T-cell-deficient mice,
and wild-type (WT) mice were stained with anti-CD3 FITC, anti-CD25 PE,
anti-CD8 APC, and anti-CD4 PerCP. Shown are representative FACS
profiles of CD4 versus CD25 on
CD4+CD8 CD3high thymocytes from 4 to 5 mice in each group. FACS profile of CD4 versus CD8 and cell number
of thymocytes was indistinguishable among these mice (data not
shown).
|
|
 |
Discussion |
In this study, we show that the size of the peripheral
CD4+CD25+ T-cell pool is regulated by at least
2 distinct mechanisms. First, in the thymus, where
CD4+CD25+ T cells are produced, a certain
TCR-MHC affinity is required for the development of
CD4+CD25+ T cells. We found that
CD4+CD25+ T cells preferentially expressed the
second TCR- chain in DO10+ TCR transgenic mice (Figure
1A) and that the development of CD4+CD25+
thymocytes was severely impaired in DO10+
TCR- / mice (Figure 3B), indicating that the
expression of the endogenous TCR- chain is required for the
development of CD4+CD25+ T cells in TCR
transgenic mice. Moreover, we found that
CD4+CD25+ thymocytes were severely decreased in
DO10+ TCR- / mice in the positively
selecting background and the negatively selecting background, whereas
CD4+CD25 thymocytes effectively developed by
transgenic TCR in DO10+ TCR- / mice in
the positively selecting background (Figure 3B). Taken together, these
results indicate that the appropriate affinity of TCR to self-MHC for
the development of CD4+CD25+ thymocytes is
different from that of CD4+CD25 thymocytes
and that the interaction of TCR with self-MHC at a certain affinity is
essential for the development of CD4+CD25+
thymocytes. Second, in the periphery, B cells regulate the expansion and/or survival of the developed CD4+CD25+ T
cells. We found that, in contrast to the thymus,
CD4+CD25+ T cells were readily detected in the
spleens of DO10+ TCR- / mice in
positively selecting background (Figure 3C), suggesting that a small
number of CD4+CD25+ T cells that developed in
the thymus might have expanded in the periphery. In addition, we found
that the number of splenic CD4+CD25+ T cells,
but not of CD4+CD25+ thymocytes, was decreased
in B-cell-deficient mice (Figures 4, 5). Therefore, B cells may
control the peripheral pool of CD4+CD25+ T
cells, possibly by inducing the expansion or prolonging the survival of
these cells.
Although it is accepted that CD4+CD25+ T cells
need activation by TCR for regulatory function, the antigen specificity
of CD4+CD25+ T cells is unknown. We found that
CD4+CD25+ thymocytes were severely decreased in
DO10+ TCR- / mice in negatively selecting
H-2b background (Figure 3). Moreover, we found that
Mtv-9-induced clonal deletion of TCR V- 5 cells proceeded normally
in CD4+CD25+ T cells in BALB/c mice (data not
shown). Furthermore, Papiernik et al29 have shown that
Mls-1a-induced clonal deletion of TCR V- 6 cells is also
normal in CD4+CD25+ T cells. These findings
indicate that CD4+CD25+ T cells are not
resistant to clonal deletion in thymus. Recently, an altered
negative-selection model of CD4+CD25+ T-cell
development was proposed.3 In this model, the suboptimal stimulation of thymocytes with low-affinity self-antigens would result
not in deletion but in a permanent change in TCR signaling. Although we
could not identify the TCR-MHC affinity that specifically induced the
development of CD4+CD25+ T cells,
identification will extend the understanding of the nature of
CD4+CD25+ T cells.
Although the expression of dual TCR- chain is not essential for the
development of CD4+CD25+ T cells (Figure 2),
CD4+CD25+ T cells preferentially express the
second TCR- chain in DO10+ mice (Figure 1). In addition,
though transgenic TCR- expression is not sufficient for the
development of CD4+CD25+ T cells in
DO10+ mice (Figure 3), the ligation of transgenic TCR has
been shown to be sufficient for the regulatory function of
CD4+CD25+ T cells.10,11 These
findings suggest that both TCRs on dual TCR- -expressing cells are
functional for their regulatory activity of
CD4+CD25+ T cells. Therefore, dual TCR-
chain expression may increase the chance for TCR signaling of
CD4+CD25+ T cells.
We found that B cells played a significant role in the regulation of
the CD4+CD25+ T-cell pool in the spleen (Figure
4) but not in the development of CD4+CD25+ T
cells in the thymus (Figure 5). Because it has been shown that B7/CD28
interaction8 and CD40/CD40L interaction15
regulate the CD4+CD25+ T-cell pool in
periphery, B cells may regulate the CD4+CD25+
T-cell pool through B7/CD28 interaction or CD40/CD40L interaction. Recently, it has been shown that the number of dividing cells is
modestly increased in CD4+CD25+ T cells
compared with that in CD4+CD25 T cells in
periphery.29 Moreover, we found that apoptotic cells, which were assessed as annexin V binding cells, were not increased in
CD4+CD25+ T cells (data not shown). Thus, it is
likely that B cells regulate the cell expansion of
CD4+CD25+ T cells in periphery.
Another subset of CD4+ regulatory T cells, isolated after T
cells were activated with alloantigens in the presence of IL-10, was
termed type 1 T regulatory (Tr1) cells.30 Tr1 cells are distinct from classical Th1 or Th2 cells in that they produce large
amounts of IL-10 and moderate amounts of transforming growth factor- .30 Significantly, Tr1 cells suppress immune
responses in vitro and in vivo through a mechanism dependent on the
production of the immunoregulatory cytokine IL-10.31 In
contrast, the regulatory function of CD4+CD25+
T cells is independent of IL-109. Although it is still
possible that they are in fact the same subset of regulatory T cells in
different stages of differentiation, the observation that
CD4+CD25+ T cells cannot be differentiated from
naive CD4+CD25 T cells in
vitro,7,9,14 whereas Tr1 cells can be differentiated from
naive cells,30 favors the hypothesis that
CD4+CD25+ T cells and Tr1 cells are 2 distinct
regulatory T cells with similar functions. Moreover, though NK T cells
have been shown to be involved in the development of IL-10-dependent
regulatory T cells,32 NK T cells were not required for the
development of CD4+CD25+ T cells (Figures 4,
5). These observations also support the above hypothesis.
In the past 10 years, a great deal has been learned about the
regulation of the CD25 gene. It is known that the CD25 gene has at
least 3 important elements for regulation, denoted positively regulatory regions (PRR) I, II, and III.33 NF- B and SRF
bind PRRI, Elf-1 and HMG-I (Y) bind PRRII, and Stat5 and Elf-1 bind PRRIII.33 Although PRRI is essential for
mitogen-antigen-mediated induction of the gene and PRRIII is essential
for IL-2-induced gene expression, PRRII is essential for transcription
in response to either mitogen or IL-2. Thus, the CD25 gene can be
controlled not only by activation-dependent signals (NF- B and Stat5)
but also by lineage-specific signals (Elf-1). Consistent with these in
vitro findings, we found that the CD4+CD25+ T
cells were decreased in both DO10+ TCR- /
mice (Figure 3) and DO10+ Stat5a /
mice,34 suggesting that both TCR-mediated signaling and
Stat5-mediated signaling are required for the development of
CD4+CD25+ T cells in vivo. More detailed
mechanisms will be uncovered by promoter analyses of the CD25 gene in
CD4+CD25+ T cells.
In summary, we have shown that the peripheral pool of
CD4+CD25+ T cells is regulated at least 2 distinct levels. First, a certain TCR-MHC affinity is required for the
development of CD4+CD25+ T cells in thymus.
Second, B cells are required for the expansion of
CD4+CD25+ T cells in periphery. The
identification of TCR-MHC affinity that preferentially induces the
development of CD4+CD25+ T cells will extend
our understanding of the nature of CD4+CD25+ T cells.
 |
Note added in proof |
After our submission of this paper to Blood, Jordan et al
reported that selection of CD4+CD25+ thymocytes
required a TCR with high affinity for a self-peptide.35
 |
Acknowledgments |
We thank Dr T. Saito for BALB/c RAG-2 / mice, Dr
D. Y. Loh for DO10+ mice, and Drs. K. M. Murphy,
K. Suzuki, and S.-I. Kagami for valuable discussions.
 |
Footnotes |
Submitted March 27, 2001; accepted July 9, 2001.
Supported in part by grants from the Ministry of Education, Science and
Culture, Japan and from Uehara Memorial Foundation.
The publication costs of this
article were defrayed in part by
page charge payment. Therefore,
and solely to indicate this fact,
this article is hereby marked
"advertisement"
in accordance with 18 U.S.C.
section 1734.
Reprints: Hiroshi Nakajima, Dept of Internal Medicine II,
Chiba University School of Medicine, 1-8-1 Inohana, Chiba 260-8670, Japan; e-mail: nakajimh{at}intmed02.m.chiba-u.ac.jp.
 |
References |
1.
Mason D, Powrie F.
Control of immune pathology by regulatory T cells.
Curr Opin Immunol.
1998;10:649-655[CrossRef][Medline]
[Order article via Infotrieve].
2.
Roncarolo MG, Levings MK.
The role of different subsets of regulatory cells in controlling autoimmunity.
Curr Opin Immunol.
2000;12:676-683[CrossRef][Medline]
[Order article via Infotrieve].
3.
Shevach EM.
Regulatory T cells in autoimmunity.
Annu Rev Immunol.
2000;18:423-449[CrossRef][Medline]
[Order article via Infotrieve].
4.
Sakaguchi S.
Regulatory T cells: key controllers of immunologic self-tolerance.
Cell.
2000;101:455-458[CrossRef][Medline]
[Order article via Infotrieve].
5.
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M.
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor -chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.
J Immunol.
1995;155:1151-1164[Abstract].
6.
Asano M, Toda M, Sakaguchi N, Sakaguchi S.
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
J Exp Med.
1996;184:387-396[Abstract/Free Full Text].
7.
Suri-Payer E, Amar AZ, Thornton AM, Shevach EM.
CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells.
J Immunol.
1998;160:1212-1218[Abstract/Free Full Text].
8.
Salomon B, Lenschow DJ, Rhee L, et al.
B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.
Immunity.
2000;12:431-440[CrossRef][Medline]
[Order article via Infotrieve].
9.
Thornton AM, Shevach EM.
CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.
J Exp Med.
1998;188:287-296[Abstract/Free Full Text].
10.
Takahashi T, Kuniyasu Y, Toda M, et al.
Immunologic self-tolerance maintained by CD25+ CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.
Int Immunol.
1998;10:1969-1980[Abstract/Free Full Text].
11.
Thornton AM, Shevach EM.
Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific.
J Immunol.
2000;189:183-190.
12.
Read S, Malmstrom Y, Powrie F.
Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+ CD4+ regulatory cells that control intestinal inflammation.
J Exp Med.
2000;192:295-302[Abstract/Free Full Text].
13.
Takahashi T, Tagami T, Yamazaki S, et al.
Immunologic self-tolerance maintained by CD25+ CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.
J Exp Med.
2000;192:303-331[Abstract/Free Full Text].
14.
Kuniyasu Y, Takahashi T, Itoh M, Shimizu J, Toda G, Sakaguchi S.
Naturally anergic and suppressive CD25+ CD4+ T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation.
Int Immunol.
2000;12:1145-1155[Abstract/Free Full Text].
15.
Kumanogoh A, Wang X, Lee I, et al.
Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development.
J Immunol.
2001;166:353-360[Abstract/Free Full Text].
16.
Papiernik M, de Moraes ML, Pontoux C, Vasseur F, Penit C.
Regulatory CD4 T cells: expression of IL-2R chain, resistance to clonal deletion and IL-2 dependency.
Int Immunol.
1998;10:371-378[Abstract/Free Full Text].
17.
Suzuki K, Nakajima H, Saito Y, Saito T, Leonard WJ, Iwamoto I.
Jak3 is essential for common cytokine receptor chain ( c)-dependent signaling: comparative analysis of c, Jak3, and c and Jak3 double deficient mice.
Int Immunol.
2000;12:123-132[Abstract/Free Full Text].
18.
Itoh M, Takahashi T, Sakaguchi N, et al.
Thymus and autoimmunity: production of CD25+ CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.
J Immunol.
1999;162:5317-5326[Abstract/Free Full Text].
19.
Kitamura D, Roes J, Kuhn R, Rajewsky K.
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin µ chain gene.
Nature.
1991;350:423-426[CrossRef][Medline]
[Order article via Infotrieve].
20.
Cui J, Shin T, Kawano T, et al.
Requirement for V 14 NKT cells in IL-12-mediated rejection of tumors.
Science.
1997;278:1622-1626[CrossRef].
21.
Murphy KM, Heimberger AB, Loh DY.
Induction by antigen of intrathymic apoptosis of CD4+ CD8+ TCRlo thymocytes in vivo.
Science.
1990;250:1720-1723[Abstract/Free Full Text].
22.
Shinkai Y, Koyasu S, Nakayama K, et al.
Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes.
Science.
1993;259:822-825[Abstract/Free Full Text].
23.
Mombaerts P, Clarke AR, Rudnicki MA, et al.
Mutations in T-cell antigen receptor genes and block thymocyte development at different stages.
Nature.
1992;360:225-231[CrossRef][Medline]
[Order article via Infotrieve].
24.
Marrack P, Shimonkevitz R, Hannum C, Haskins K, Kappler J.
The major histocompatibility complex-restricted antigen receptor on T cells, IV: an antiidiotypic antibody predicts both antigen and I-specificity.
J Exp Med.
1983;158:1635-1646[Abstract/Free Full Text].
25.
Malissen M, Trucy J, Jouvin-Marche E, Cazenave PA, Scollay R, Malissen B.
Regulation of TCR  |